General
Preferred name
ERTAPENEM
Synonyms
MK-826 ()
L-749345 ()
ERTAPENEM SODIUM ()
Invanz ()
MK826 ()
MK-0826 ()
Ertapenem sodium salt ()
Ertapenem (sodium salt) ()
P&D ID
PD010113
CAS
153773-82-1
153832-38-3
153832-46-3
Tags
natural product
drug
available
Approved by
EMA
FDA
First approval
2001
Drug Status
investigational
approved
Drug indication
Bacterial infection
Max Phase
Phase 4
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure
P&D probe-likeness score
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION
Ertapenem is a carbapenem and broad-spectrum β-lactam antibacterial.
(GtoPdb)
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Compound Sets
18
AdooQ Bioactive Compound Library
Cayman Chemical Bioactives
ChEMBL Approved Drugs
ChEMBL Drugs
DrugBank
DrugBank Approved Drugs
DrugCentral
DrugCentral Approved Drugs
DrugMAP
DrugMAP Approved Drugs
Guide to Pharmacology
MedChem Express Bioactive Compound Library
Natural product-based probes and drugs
NCATS Inxight Approved Drugs
Other bioactive compounds
ReFrame library
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
74
Molecular Weight
475.14
Hydrogen Bond Acceptors
7
Hydrogen Bond Donors
5
Rotatable Bonds
7
Ring Count
4
Aromatic Ring Count
1
cLogP
0.94
TPSA
156.27
Fraction CSP3
0.45
Chiral centers
6.0
Largest ring
6.0
QED
0.36
Structural alerts
0
No structural alerts detected
Related compounds
Custom attributes
(extracted from source data)
Pathway
Microbiology&virology
Anti-infection
Target
antibiotic
Bacterial
MOA
Antibiotic
Biosynthetic Origin
Peptide (beta-Lactam)
Therapeutic Indication
Antibacterial
Therapeutic Class
Antimicrobial
Antibiotics
Source data
